Understanding the law, science, and technology

Our clients’ business and IP assets are global; protecting these assets across jurisdictions is increasingly challenging. With offices around the world and experience with multinational companies, Finnegan has the resources and experience to formulate and execute global strategies for pharmaceutical companies. The fast pace of new discoveries and their commercial applications require a comprehensive grasp of the IP legal issues and the industry insight to understand the scientific and strategic implications of the advancements.

With experience addressing virtually every type of IP issue for our pharmaceutical clients, we help by:

• Representing clients in complex pharmaceutical patent infringement and trade secret cases, including Hatch-Waxman litigation
• Litigating high value products in district and appellate courts with experienced trial and appellate teams
• Developing and executing prosecution strategies to both protect a client’s products and analyze those of its competitors, thus helping ensure that the client realizes value from its IP assets
• Preparing and negotiating licenses, assessing the licensing value of competitors’ patents, and guiding clients in decisions to license 
• Providing due diligence for merger and acquisition and partnership targets 
• Providing counsel on business-related matters, including antitrust and competition issues 
• Determining priority in complex interferences 
• Advising on potential litigation strategies, and asserting and defending patents in court
• Providing trademark prosecution and counseling services 

We work with clients innovating and advancing science in myriad fields, including:

• Antibody therapies—small and large molecules 
• Atypical antipsychotic drugs
• Sustained-release formulations 
• Vaccines